Precision treatment for prostate cancer
Imaging and software experts developed a new 3D imaging technology that can improve the outcome of prostate cancer treatment. Under the PTPS project, new technologies were developed by Israeli company INSIGHTEC, together with German researchers. These technologies aid in the performance of non-invasive, focused ultrasound treatment. Guided by magnetic resonance images on a screen, doctors direct a high-intensity ultrasound beam, using heat generated at the beam focused to destroy cancerous tissue. Until now, the best equipment on the market provided 2D imaging.
The more realistic 3D display helps doctors avoid damaging organs near the prostate, such as the bladder, rectum, sphincter and nerve muscles. This reduces the risk of undesirable effects leading to incontinency or impotence. In the EU, more than 350,000 men per year are diagnosed with prostate cancer. INSIGHTEC is marketing the system, which mounts on typical MR scanner tables.
Project funded by Israel European R&D Directorate ISERD (Israel), and German Federal Ministry of Education and Research (Germany)
- Fraunhofer MEVIS (Germany – research organisation)
- INSIGHTEC (Israel – SME and leading role)
- Mediri GmbH (Germany – SME)